← 返回行业资讯|行业资讯·商业管理Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame商业管理2026-08-05 , 04:17:00分享到The Danish drugmaker also revealed an improved outlook for the year. Source:MarketWatch友情提醒:请广大读者理性看待市场信息,切实提高风险意识。站内所有内容仅系市场信息或相关方观点,不构成任何形式投资建议。延伸阅读CFTC sues Cash FX, alleges $950M crypto-linked forex schemeThe CFTC claimed that Cash FX engaged in minimal forex trading and misappropriated most of the participant funds. Source:Cointelegraph2026-09-26 , 14:59:29Solana’s 150-millisecond settlement upgrade reaches second public test networkAlpenglow is running on both public test networks, giving application teams a place to check their software before the live blockchain switches. Source:CoinDesk2026-09-26 , 13:00:00XRP Ledger’s Batch upgrade slips to Oct. 9 after validator support resetsThe feature would let users bundle up to eight transactions, including assetandpayment transfers, but a brief drop below the network’s 80% support threshold…2026-09-26 , 12:30:00Bitcoin could soon get Zcash-style 'shielded' privacy without changing its rulesResearchers have mapped out private bitcoindenominated transfers that run alongside Bitcoin, but the system still lacks a finished way to lock up real BTC and…2026-09-26 , 12:02:13来源:https://www.marketwatch.com/story/the-wegovy-pills-surprise-miss-is-one-reason-novo-nordisks-stock-is-down-ec0fe43d